9 results match your criteria: ""Andreas Sygros" Hospital for Cutaneous and Venereal Diseases[Affiliation]"
J Eur Acad Dermatol Venereol
July 2024
Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Skin Appendage Disord
December 2023
2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, "Attikon" General University Hospital, Athens, Greece.
Introduction: Treatment of hidradenitis suppurativa (HS) is challenging, and in Hurley stage I, it is based on topical measures. Our aim was to compare the efficacy and safety of topical resorcinol 10% with topical clindamycin 1% and no therapy, in Hurley stage I HS.
Methods: In this open, prospective, randomized trial, we studied 60 Hurley stage I patients with IHS4 ≤10.
Dermatol Pract Concept
October 2023
Service de Dermatologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; Université Claude-Bernard-Lyon Lyon, Lyon, France and Lyons cancer research center UMR INSERM U1052 - CNRS5286 - UCBL1 Lyon France.
Dermatology
October 2023
First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.
Background: Peripheral globules (PG) in melanocytic lesions represent a concerning dermoscopic feature since they might be present in growing nevi and melanomas. Their natural evolution has not been fully elucidated, and an age-based management approach has been recommended.
Objectives: The aim of this study was to calculate the growth rate of lesions with PG and investigate possible association with age, sex, location, and the global dermoscopic pattern.
Indian J Dermatol
January 2022
First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, "Andreas Sygros" Hospital for Cutaneous and Venereal Diseases, Athens, Greece.
Background: Hidradenitis suppurutiva (HS) is a chronic auto-inflammatory disease with recurrent painful deep-seated nodules.
Aims: The aim of this study was to qualitatively assess patients' perception for HS.
Methods: A descriptive two-step questionnaire survey was conducted from January 2017 to December 2018.
Medicina (Kaunas)
February 2023
First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54643 Thessaloniki, Greece.
The group of histopathologically aggressive BCC subtypes includes morpheaform, micronodular, infiltrative and metatypical BCC. Since these tumors are at increased risk of recurring, micrographically controlled surgery is considered the best therapeutic option. Although dermoscopy significantly improves the clinical recognition of BCC, scarce evidence exists on their dermoscopic criteria.
View Article and Find Full Text PDFToxins (Basel)
May 2022
Dermatological Clinic, Polytechnic Marche University, 60200 Ancona, Italy.
Among the forms of idiopathic hyperhidrosis, those involving the forehead have the greatest impact on patients' quality of life, as symptoms are not very controllable and are difficult to mask for patients. Although the local injection therapy with Incobotulinum toxin type A (IncoBTX-A therapy) can be considered a rational treatment, data from the literature describing both efficacy and safety of the treatment over the long term are poor. The aim of this report is to describe the single-center experience of five patients seeking treatment, for forehead hyperhidrosis with IncoBTX-A.
View Article and Find Full Text PDFJ Clin Med
October 2021
First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece.
: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder of the follicular epithelium. The aim of the study was to investigate the effectiveness of colchicine on the clinical outcomes of HS patients, and to evaluate wither colchicine as monotherapy or in combination with doxycycline would provide better outcomes. : A retrospective study was conducted including 44 patients with established HS, divided into three groups.
View Article and Find Full Text PDFClin Exp Dermatol
August 2019
First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, Andreas Sygros Hospital for Cutaneous and Venereal Diseases, 5 I. Dragoumi Street, GR-16121, Kaisariani, Athens, Greece.